{"resourceType":"ValueSet","id":"valueset-piroxicam-exclude","text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Include these codes as defined in <a href=\"http://www.nlm.nih.gov/research/umls/rxnorm\"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>106002</td><td>Piroxicam 0.005 MG/MG Topical Gel</td></tr><tr><td>377958</td><td>Piroxicam Topical Gel</td></tr><tr><td>1159307</td><td>Piroxicam Topical Product</td></tr></table></li></ul></div>"},"url":"http://hl7.org/fhir/uv/pddi/ValueSet/valueset-piroxicam-exclude","version":"1.0.0-ballot","name":"Valueset_piroxicam_exclude","title":"Exclude Piroxicam Medications Value Set","status":"draft","experimental":true,"date":"2018-07-02","publisher":"HL7 Clinical Decision Support Workgroup","contact":[{"telecom":[{"system":"url","value":"http://hl7.org/Special/committees/dss"}]}],"description":"ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations.","jurisdiction":[{"coding":[{"system":"http://unstats.un.org/unsd/methods/m49/m49.htm","code":"001"}]}],"purpose":"To refine valueset for Warfarin + NSAID PDDI-CDS","copyright":"(copyright expectations unknown)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"106002","display":"Piroxicam 0.005 MG/MG Topical Gel"},{"code":"377958","display":"Piroxicam Topical Gel"},{"code":"1159307","display":"Piroxicam Topical Product"}]}]}}